Be the first to like this
The company is expected to expand its revenue at a CAGR of 25.0% from FY’2012 to FY’2017. The company is planning to increase its product portfolio by increasing its expenditure on research and development. It is expected that the company will increase its expenditure on research and development to INR 100 crore per year in the next four years. These researches will bring new and innovative products and will improve the existing product portfolio of the company. This will lead to production of more cost efficient and qualitative products and will increase the revenues and operating margin of the company. Additionally, the company is planning to introduce genetically modified (GM) seeds in food items in Bangladesh and Philippines. Introduction of GM seeds will increase the company’s revenues from the international seed market.
The report focuses on providing analysis on the company’s valuation in the industry and also provides for a detailed analysis of the company’s enterprise value and it’s positioning against its competitors.
For more information on the industry research report please refer to the below mentioned link: